Negative 68Ga-FAPI-04 Uptake on PET/CT in HNF-1α-mutated Hepatocellular Adenoma: A Distinctive Feature for Differentiating From Hepatocellular Carcinoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 41771036.
- Also identified by DOI 10.1097/RLU.0000000000006214.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 37-year-old woman was incidentally found to have a hepatic lesion on ultrasound. Serum tumor markers, including AFP, CEA, and CA19-9, were normal. Gd-EOB-DTPA-enhanced MRI revealed a fat-containing lesion with arterial phase hyperenhancement, rapid washout, hypointensity in the hepatobiliary phase, and no diffusion restriction, making it difficult to differentiate between hepatic adenoma (HCA) and small hepatocellular carcinoma (HCC). 18F-FDG PET/CT revealed intense uptake, raising suspicion of malignancy, while 68Ga-FAPI-04 PET/CT demonstrated negligible uptake. Histopathology confirmed hepatocyte nuclear factor 1α (HNF1α)-mutated hepatocellular adenoma (H-HCA). This case may provide valuable insights into differentiating H-HCA from small HCC.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Liver Neoplasms
- Carcinoma, Hepatocellular
- Adenoma, Liver Cell
- Hepatocyte Nuclear Factor 1-alpha
- Mutation